Phase 2 High Risk Smoldering Multiple Myeloma Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
Multiple MyelomaSmoldering Multiple MyelomaHigh Risk Smoldering Multiple Myeloma
Irene Ghobrial, MD52 enrolled3 locationsNCT05469893
Recruiting
Phase 2
Ciltacabtagene Autoleucel in High-Risk Smoldering Multiple Myeloma
High Risk Smoldering Multiple Myeloma
PETHEMA Foundation20 enrolled1 locationNCT06574126